NMTC

Neuroone Medical Technologie Cross-source read$1.56 1.27%
Health CareCUSIP 64130M308· EOD Sep 11, 2026

Among active 13F managers last quarter, 5 opened and 1 reduced; the largest holder to move was Bard Associates Inc (new position). Over the last 180 days, 1 insider bought and 1 insider sold, a net +$24K in open-market trades.

Tracked 13F holders
10
13F value (tracked)
$3.5M
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
5 adding · 1 trimming
Insiders · Form 4 open-market, 180d
1 buying · 1 selling · +$24K
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$1.56 1.27%5Y -94.4%
$1.44$8.58$15.72$22.86$30.0120212022202320242025202643422554
Hover for who · click for detailEnd-of-day closing prices52w $1.52 – $6.36

Who owns NMTC?

10 tracked 13F filers · ranked by shares held

10 tracked 13F filers disclose a position in NMTC as of the latest SEC 13F filings, a combined $3.5M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Vanguard Capital Management LLC353K
$1.1M
New
+353K sh
Q2 2026
2Bard Associates Inc305K
$929K
New
+305K sh
Q2 2026
3Perkins Capital Management Inc245K
$744K
New
+245K sh
Q2 2026
4Geode Capital Management, LLC94K
$284K
New
+94K sh
Q2 2026
5Vanguard Fiduciary Trust Co49K
$149K
New
+49K sh
Q2 2026
6Essex Investment Management Co LLC44K
$132K
New
+44K sh
Q2 2026
7BlackRock, Inc.25K
$76K
New
+25K sh
Q2 2026
8Citadel Advisors LLC15K
$46K
New
+15K sh
Q2 2026
9Legato Capital Management LLC10K
$31K
New
+10K sh
Q2 2026
10SBI Securities Co., Ltd.13
$40
−35%
Reduced · −7 sh
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is NMTC being bought or sold by institutions?

Last quarter, 5 funds opened a new position in NMTC, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
5
funds took a first position
Reduced
1
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own NMTC also own

CompanyCo-held byTheir position there
Apple IncAAPL6 funds$2.3B
Microsoft CorpMSFT6 funds$1.5B
Merck & Co. Inc.MRK6 funds$256.0M
Verizon Communications IncVZ6 funds$95.4M
Crexendo IncCXDO6 funds$11.5M
Amazon.com IncAMZN5 funds$2.7B
Alphabet Inc-CL AGOOGL5 funds$1.2B
Eli Lilly & CoLLY5 funds$1.2B
Advanced Micro DevicesAMD5 funds$978.7M
Alphabet Inc-CL CGOOG5 funds$971.4M
Micron Technology IncMU5 funds$824.3M
Abbott LaboratoriesABT5 funds$782.4M

Ranked by how many of NMTC's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in NMTC.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$67K
1 insider
Sells · 180d
$43K
1 insider
Net · 180d
$24K
3 open-market transactions
DateInsiderRoleActionSharesValue
Aug 27, 2026Wambeke David J.Chief Business OfficerBuy (P)33K$67K
Jun 30, 2026Christianson MarkMarket Development DirectorSell (S)10K$32K
Mar 30, 2026Christianson MarkBusiness Development DirectorSell (S)15K$11K
Mar 13, 2026Christianson MarkBusiness Development DirectorSell (S)100$80
Mar 12, 2026Christianson MarkBusiness Development DirectorSell (S)817$654
Mar 11, 2026Christianson MarkBusiness Development DirectorSell (S)2K$2K
Mar 10, 2026Christianson MarkBusiness Development DirectorSell (S)12K$9K
Mar 1, 2026Wambeke David J.Chief Business OfficerBuy (P)1.0M$670K
Sep 5, 2025Christianson MarkBusiness Development DirectorSell (S)30K$22K
Jun 4, 2025Christianson MarkBusiness Development DirectorSell (S)10K$6K
May 22, 2025Christianson MarkBusiness Development DirectorSell (S)9K$6K
May 21, 2025Christianson MarkBusiness Development DirectorSell (S)14$9

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
01
Insiders
Form 4 open-market
11+$24K
US House
STOCK Act trades
00$0
Sector rotation
NMTC is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Share classes

Class13F holdersValue held
64130M209Stock15 funds$763K
NMTCthis pageCOM10 funds$3.5M

Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.

Recent filings

15 most recent

Keep exploring

Connected entities for NMTC

Browse more

Build

Ask your agent what changed in NMTC

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/NMTC/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for NMTC.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for NMTC. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.